MML Investors Services LLC grew its stake in shares of Aurora Cannabis Inc (NYSE:ACB) by 54.9% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 103,341 shares of the company’s stock after acquiring an additional 36,646 shares during the period. MML Investors Services LLC’s holdings in Aurora Cannabis were worth $808,000 at the end of the most recent quarter.
A number of other hedge funds also recently made changes to their positions in ACB. Mackey Komara & Dankovich LLC acquired a new position in shares of Aurora Cannabis in the 2nd quarter valued at about $27,000. Executive Wealth Management LLC boosted its holdings in shares of Aurora Cannabis by 102.1% in the 2nd quarter. Executive Wealth Management LLC now owns 3,900 shares of the company’s stock valued at $30,000 after buying an additional 1,970 shares during the period. Kistler Tiffany Companies LLC boosted its holdings in shares of Aurora Cannabis by 77.9% in the 2nd quarter. Kistler Tiffany Companies LLC now owns 4,075 shares of the company’s stock valued at $32,000 after buying an additional 1,785 shares during the period. Resources Investment Advisors LLC. lifted its position in Aurora Cannabis by 825.7% in the 2nd quarter. Resources Investment Advisors LLC. now owns 4,962 shares of the company’s stock valued at $39,000 after purchasing an additional 4,426 shares during the last quarter. Finally, Manchester Financial Inc. bought a new stake in Aurora Cannabis in the 2nd quarter valued at about $43,000. 8.88% of the stock is owned by institutional investors.
Several analysts recently weighed in on the stock. Stifel Nicolaus reiterated a “sell” rating and issued a $5.00 price objective (down from $7.00) on shares of Aurora Cannabis in a research report on Thursday, September 12th. LADENBURG THALM/SH SH assumed coverage on shares of Aurora Cannabis in a research report on Wednesday, July 17th. They issued a “buy” rating and a $9.00 price objective on the stock. Piper Jaffray Companies set a $7.00 price objective on shares of Aurora Cannabis and gave the company a “hold” rating in a research report on Friday, September 13th. Zacks Investment Research upgraded shares of Aurora Cannabis from a “sell” rating to a “hold” rating in a research report on Thursday, September 12th. Finally, Compass Point set a $8.00 price objective on shares of Aurora Cannabis and gave the company a “hold” rating in a research report on Thursday, September 12th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and seven have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $8.43.
Shares of ACB traded down $0.05 during mid-day trading on Thursday, hitting $5.22. The company’s stock had a trading volume of 6,033,942 shares, compared to its average volume of 12,965,318. The firm has a 50-day moving average price of $5.97 and a 200 day moving average price of $7.62. The stock has a market capitalization of $5.56 billion, a price-to-earnings ratio of -23.70 and a beta of 2.47. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.52 and a quick ratio of 1.14. Aurora Cannabis Inc has a fifty-two week low of $4.58 and a fifty-two week high of $12.52.
Aurora Cannabis Company Profile
Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.
Further Reading: How Do Mutual Funds Work?
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.